Enter your login e-mail to the account
Search
- Primary myelofibrosis – current view of pathophysiology, prognosis and treatment
Prof. MUDr. Elena Tóthová, CSc., MUDr. Adriana Kafková, PhD.
(5/2018, Spectrum ) - Essential thrombocythemia
doc. MUDr. Martin Mistrík, PhD., MUDr. Zuzana Sninská, PhD., MUDr. Antónia Hatalová, MUDr. Denisa Jankovičová, MUDr. Tatiana Prigancová, doc. MUDr. Angelika Bátorová, PhD.
(6/2013, Review articles ) - Diagnostics and treatment of chronic myelomonocytic leukemia in the years 2000-2013 – results from 2 hematologic centres
MUDr. Peter Rohoň, Ph.D., MUDr. Petra Bělohlávková, MUDr. Zuzana Rusiňáková, MUDr. Jaroslava Voglová, MUDr. Luděk Raida, Ph.D., MUDr. Alžběta Zavřelová, doc. MUDr. Pavel Žák, CSc.
(3/2014, Original articles & case reports ) - Myelofibrosis – diagnosis, management, new treatment options
MUDr. Anna Vallová
(6/2015, Review articles ) - Solving clinical problems in the treatment of myelofibrosis - how to prevent ruxolitinib failure
MUDr. Antónia Hatalová, PhD.
(4/2022, Review articles ) - Polycythemia vera – treatment options and today‘s practice
MUDr. Adriana Kafková, PhD., prof. MUDr. Elena Tóthová, CSc.
(4/2019, Review articles ) - Myelofibróza – posúdenie nových liečebných možností
MUDr. Antónia Hatalová
(5/2012, Editorial ) - Bioptická diagnostika myeloproliferatívnych neoplázií
MUDr. Juraj Marcinek, PhD., prof. MUDr. Lukáš Plank, CSc.
(2/2018, Spectrum ) - Diagnosis prefibrotic stage of myelofibrosis – reason for optimism and concern
MUDr. Antónia Hatalová, PhD., prof. MUDr. Angelika Bátorová, PhD.
(6/2020, Review articles ) - Polycytémia vera – súčasný pohľad na diagnostiku a liečbu
MUDr. Antónia Hatalová, PhD., MUDr. Jana Malinová, doc. MUDr. Martin Mistrík, PhD., prof. MUDr. Angelika Bátorová, CSc.
(3/2018, Spectrum ) - Diagnostics and treatment of essential thrombocytemia – is there yet anything new?
Prof. MUDr. Mikuláš Hrubiško, CSc.
(4/2015, Review articles ) - Treatment of myelofibrosis in time ruxolitinib
MUDr. Antónia Hatalová, PhD., prof. MUDr. Angelika Bátorová, PhD.
(2/2020, Review articles ) - New trends in diagnosis and treatment of essential thrombocythemia and myelofibrosis
prof. MUDr. Elena Tóthová, CSc., MUDr. Adriana Kafková, PhD.
(6/2012, Review articles ) - Options of treatment for primary myelofibrosis with significant splenomegaly
MUDr. Kamil Diľ
(S2/2020, Case reports ) - The effect of ruxolitinib on quality of life – a case report
MUDr. Daniela Kubincová
(S2/2020, Case reports ) - Clinical experience with successful ruxolitinib treatment in a patient diagnosed with polycythemia vera
MUDr. Adriana Kafková, PhD., prof. MUDr. Elena Tóthová, CSc.
(S2/2020, Case reports ) - Polycytemia vera – how to treat further the patient after exhaustion of conventional therapy (hydroxyurea and interferon)
MUDr. Juraj Chudej, PhD., MUDr. Matej Hrnčár, PhD., doc. MUDr. Juraj Sokol, PhD.
(S2/2020, Case reports ) - Recommendations for the treatment of patients with polycythaemia vera in the Slovak Republic
MUDr. Antónia Hatalová, PhD., MUDr. Alexander Wild, MUDr. Anna Vallová, MUDr. Tomáš Guman, PhD., MUDr. Monika Hlebašková, MUDr. Juraj Chudej, PhD., MUDr. Emília Flochová, PhD., MUDr. Ľubica Váleková, PhD., MUDr. Ľubica Lukáčová
(S1/2022, Supplement ) - Esenciálna trombocytémia – mení sa niečo v diagnostike a liečbe v roku 2018?
Prof. MUDr. Mikuláš Hrubiško, CSc.
(4/2018, Spectrum )
- Thrombo-haemorrhagic syndrome in myeloproliferative neoplasias
prof. MUDr. Peter Kubisz, DrSc., doc. MUDr. Ján Staško, PhD., mim. prof., MUDr. Zuzana Jedináková, PhD.
(1/2016, Review articles )